4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-008987
Chairman and CEO bought 31,100 shares at an average $1.80 ($56,116)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-02-10 | Purchase | +9,200 | $1.71 | $15,732 | 10,315,893 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-11 | Purchase | +17,500 | $1.84 | $32,200 | 10,333,393 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-12 | Purchase | +4,400 | $1.86 | $8,184 | 10,337,793 | D |
| Open-market purchases · 31,100 sh · avg $1.80 · $56,116 | |||||||
Loading xslF345X03/doc4.xml…